FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein W is N; Y is C; R1 is absent; R2 is either halogen, hydroxy or cycloalkyl; R3 is -OR12; R4 is H; R5 is H; R6 and R7 together form a 3- to 8-membered cycloalkyl ring, optionally substituted with R15, R15', R16 and/or R16'; R8 is H; R9 is H; R10 is -COOH; R11 is H; R12 is C1-6 alkyl substituted with methoxy or cyclopropyl; and R15, R15, R16 and/or R16' are independently C1-6 alkyl. The invention also relates to a pharmaceutical composition containing a therapeutically effective amount of a compound of Formula I.
EFFECT: obtaining new compounds and a pharmaceutical composition based on them which can be used in medicine as effective agents for the treatment of hepatitis B.
8 cl, 3 tbl, 36 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
BICYCLIC DERIVATIVES | 2019 |
|
RU2794894C2 |
BICYCLIC DERIVATIVES | 2019 |
|
RU2794895C2 |
NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS | 2016 |
|
RU2675622C1 |
PDE9 INHIBITOR AND ITS USE | 2018 |
|
RU2793732C2 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2702732C1 |
SUBSTITUTED 1,2-DIHYDRO[2,7]NAPHTHIRIDINES, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND APPLYING | 2003 |
|
RU2243218C1 |
THIAZOLINO-2-PYRIDONES WITH CONDENSED RINGS IN COMBINATION WITH A DRUG AGAINST TUBERCULOSIS | 2018 |
|
RU2791467C2 |
Authors
Dates
2023-07-19—Published
2018-10-05—Filed